Rxivist logo

High-throughput organoid screening enables engineering of intestinal epithelial composition

By Benjamin E Mead, Kazuki Hattori, Lauren Levy, Marko Vukovic, Daphne Sze, Juan D Matute, Jinzhi Duan, Robert Langer, Richard S Blumberg, Jose Ordovas-Montanes, Alex K Shalek, Jeffrey M Karp

Posted 28 Apr 2020
bioRxiv DOI: 10.1101/2020.04.27.063727

Barrier tissue epithelia play an essential role in maintaining organismal homeostasis, and changes in their cellular composition have been observed in multiple human diseases. Within the small intestinal epithelium, adult stem cells integrate diverse signals to regulate regeneration and differentiation, thereby establishing overall cellularity. Accordingly, directing stem cell differentiation could provide a tractable approach to alter the abundance or quality of specialized cells of the small intestinal epithelium, including the secretory Paneth, goblet, and enteroendocrine populations. Yet, to date, there has been a lack of suitable tools and rigorous approaches to identify biological targets and pharmacological agents that can modify epithelial composition to enable causal testing of disease-associated changes with novel therapeutic candidates. To empower the search for epithelia-modifying agents, we establish a first-of-its-kind high-throughput phenotypic organoid screen. We demonstrate the ability to screen thousands of samples and uncover biological targets and associated small molecule inhibitors which translate to in vivo. This approach is enabled by employing a functional, cell-type specific, scalable assay on an organoid model designed to represent the physiological cues of in vivo Paneth cell differentiation from adult intestinal stem cells. Further, we miniaturize and adapt the organoid culture system to enable automated plating and screening, thereby providing the ability to test thousands of samples. Strikingly, in our screen we identify inhibitors of the nuclear exporter Xpo1 modulate stem cell fate commitment by inducing a pan-epithelial stress response combined with an interruption of mitogen signaling in cycling intestinal progenitors, thereby significantly increasing the abundance of Paneth cells independent of known WNT and Notch differentiation cues. We extend our observation in vivo, demonstrating that oral administration of Xpo1 inhibitor KPT-330 at doses 1,000-fold lower than conventionally used in hematologic malignancies increases Paneth cell abundance. In total, we provide a framework to identify novel biological cues and therapeutic leads to rebalance intestinal stem cell differentiation and modulate epithelial tissue composition via high-throughput phenotypic screening in rationally-designed organoid model of differentiation. ### Competing Interest Statement The authors J.M.K. and R.L. hold equity in Frequency Therapeutics, a company that has an option to license IP generated by J.M.K. and R.L. and that may benefit financially if the IP is licensed and further validated. The interests of J.M.K. and R.L. were reviewed and are subject to a management plan overseen by their institutions in accordance with their conflict of interest policies.

Download data

  • Downloaded 2,665 times
  • Download rankings, all-time:
    • Site-wide: 6,872
    • In bioengineering: 94
  • Year to date:
    • Site-wide: 9,318
  • Since beginning of last month:
    • Site-wide: 10,010

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide